News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Real-time Estimate Cboe Europe Other stock markets 06:15:12 2024-05-06 am EDT			5-day change	1st Jan Change
854.2 ^DKK	+0.42%		-3.25%	+22.62%

10:46am	NOVO NORDISK : UBS sticks Neutral	ZD
06:01am	Global health heavyweights team up for climate, disease funding	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NOVO NORDISK : UBS sticks Neutral	04:46am	ZD
Global health heavyweights team up for climate, disease funding	12:01am	RE
News Highlights : Top Company News of the Day - Friday at 5 PM ET	May. 03	DJ
News Highlights : Top Company News of the Day - Friday at 7 PM ET	May. 03	DJ
Health Care Climbs as Amgen Surges on Obesity-Drug Plans - Health Care Roundup	May. 03	DJ
News Highlights : Top Company News of the Day - Friday at 3 PM ET	May. 03	DJ
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	May. 03	GL
News Highlights : Top Company News of the Day - Friday at 1 PM ET	May. 03	DJ
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition	May. 03	MT
Novo Nordisk: share price falls, analyst adjusts target	May. 03	CF
Catalent, Novo Nordisk Antitrust Review Extended by FTC	May. 03	MT
News Highlights : Top Company News of the Day - Friday at 11 AM ET	May. 03	DJ
NOVO NORDISK : DZ Bank sticks Neutral	May. 03	ZD
FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal	May. 03	DJ
News Highlights : Top Company News of the Day - Friday at 9 AM ET	May. 03	DJ
NOVO NORDISK : Stifel lowers target slightly	May. 03	CF
US FTC seeks more information on Novo Nordisk parent-Catalent deal	May. 03	RE
FTC seeks more information on Novo Holdings-Catalent deal	May. 03	RE
Transcript : Novo Nordisk A/S, Q1 2024 Earnings Call, May 03, 2024	May. 03
Ventus Therapeutics, Inc. Announces First Participant Dosed in Clinical Study with an NLRP3 Inhibitor Licensed Exclusively to Novo Nordisk	May. 03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novo Nordisk CEO: Demand for Wegovy outstrips supply

May 02, 2024 at 12:36 pm EDT

NOVO NORDISK : Q1 beat; guidance upgrade but sentiment nonetheless dampened by price reductions

May 02, 2024 at 12:09 pm EDT

Novo Nordisk doesn't disappoint

January 31, 2024 at 10:48 am EST